Biological and therapeutic implications of the tumor microenvironment in pituitary adenomas
Pituitary adenomas (PAs) are neoplasms derived from the endocrine cells of the anterior
pituitary gland. Most frequently, they are benign tumors, but may sometimes display an …
pituitary gland. Most frequently, they are benign tumors, but may sometimes display an …
Tumour microenvironment and pituitary tumour behaviour
P Marques, M Korbonits - Journal of Endocrinological Investigation, 2023 - Springer
The pituitary tumour microenvironment encompasses a spectrum of non-tumoural cells, such
as immune, stromal or endothelial cells, as well as enzymes and signalling peptides like …
as immune, stromal or endothelial cells, as well as enzymes and signalling peptides like …
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications
The microenvironment of pituitary adenomas (PAs) includes a range of non-tumoral cells,
such as immune and stromal cells, as well as cell signaling molecules such as cytokines …
such as immune and stromal cells, as well as cell signaling molecules such as cytokines …
[HTML][HTML] The immune microenviroment in somatotropinomas: from biology to personalized and target therapy
S Chiloiro, L De Marinis - Reviews in Endocrine and Metabolic Disorders, 2023 - Springer
Pituitary tumors are rare neoplasms, with a heterogeneous biological and clinical behavior,
due to their clinical course, local invasive growth, resistance to conventional therapies and …
due to their clinical course, local invasive growth, resistance to conventional therapies and …
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs
S Chiloiro, A Giampietro, M Gessi… - Journal of …, 2023 - Wiley Online Library
Somatotropinomas are pituitary tumors with a heterogenous clinical behavior. The tumor
microenvironment regulates the interaction between tumor cells and the host immune …
microenvironment regulates the interaction between tumor cells and the host immune …
[HTML][HTML] The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor
D Nie, Q Fang, J Cheng, B Li, M Li, H Wang… - Cancer Immunology …, 2022 - Springer
Context Pituitary adenoma (PA) is a common intracranial tumor. The evidence indicates that
the tumor immune microenvironment (TIME) is associated with PA and that the intestinal …
the tumor immune microenvironment (TIME) is associated with PA and that the intestinal …
[HTML][HTML] Tumor-associated macrophages: new horizons for pituitary adenoma researches
Macrophages are one of the most common infiltrating immune cells and an essential
component of tumor microenvironment. Macrophages and the soluble cytokines and …
component of tumor microenvironment. Macrophages and the soluble cytokines and …
[HTML][HTML] Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways
S Serioli, L Agostini, A Pietrantoni, F Valeri… - International journal of …, 2023 - mdpi.com
Recently, advances in molecular biology and bioinformatics have allowed a more thorough
understanding of tumorigenesis in aggressive PitNETs (pituitary neuroendocrine tumors) …
understanding of tumorigenesis in aggressive PitNETs (pituitary neuroendocrine tumors) …
[HTML][HTML] Large scale molecular studies of pituitary neuroendocrine tumors: Novel markers, mechanisms and translational perspectives
R Peculis, H Niedra, V Rovite - Cancers, 2021 - mdpi.com
Simple Summary Pituitary neuroendocrine tumors are non-cancerous tumors of the pituitary
gland, that may overproduce hormones leading to serious health conditions or due to tumor …
gland, that may overproduce hormones leading to serious health conditions or due to tumor …
[HTML][HTML] PD-L1 and tumor-infiltrating CD8+ lymphocytes are correlated with clinical characteristics in pediatric and adolescent pituitary adenomas
M Shi, Y Song, Y Zhang, L Li, J Yu, A Hou… - Frontiers in …, 2023 - frontiersin.org
Objective To investigate the levels of tumor-infiltrating CD8+ lymphocytes (CD8+ TILs) and
the expression of programmed cell death receptor ligand 1 (PD-L1) in the tumor …
the expression of programmed cell death receptor ligand 1 (PD-L1) in the tumor …